v3.26.1
Equity Incentive Plans (Summary Of Nonvested Share Activity) (Details) - USD ($)
$ / shares in Units, $ in Thousands
3 Months Ended 6 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2026
Jun. 30, 2025
May 06, 2025
Dec. 31, 2024
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Number of Shares, Outstanding at December 31, 2025     648,878      
Number of Shares, Granted     336,422      
Number of Shares, Vested     (331,954)      
Number of Shares, Outstanding at March 31, 2026 650,338   650,338      
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2025     $ 46.05      
Weighted Average Grant Date Fair Value, Granted     54.68      
Weighted Average Grant Date Fair Value, Vested     45.24      
Weighted Average Grant Date Fair Value, Outstanding at March 31, 2026 $ 50.95   $ 50.95      
Weighted Average Life Remaining, Outstanding at March 31, 2026 (in years)     1 year 4 months 9 days      
Fair value of non-vested shares     $ 16,900 $ 11,800    
Unamortized share-based compensation expense $ 17,300   17,300      
Severance Costs $ 0 $ 0 $ 1,423 0    
2016 Equity Incentive Plan [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Common shares, options to purchase common shares and restricted share units, expected to granted (in shares)         5,950,000  
Number of shares available for grant (in shares) 1,650,862   1,650,862      
Restricted Stock [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share-based Payment Arrangement, Expense     $ 4,200 3,900    
Severance Costs     $ 400      
Performance Shares [Member]            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Number of Shares, Outstanding at December 31, 2025     341,692      
Number of Shares, Granted     119,459      
Number of Shares, Vested     (111,593)      
Number of Shares, Outstanding at March 31, 2026 349,558   349,558      
Weighted Average Grant Date Fair Value, Outstanding at December 31, 2025     $ 57.97      
Weighted Average Grant Date Fair Value, Granted     56.19      
Weighted Average Grant Date Fair Value, Vested     63.08      
Weighted Average Grant Date Fair Value, Outstanding at March 31, 2026 $ 55.73   $ 55.73      
Weighted Average Life Remaining, Outstanding at March 31, 2026 (in years)     1 year 6 months      
Unamortized share-based compensation expense $ 10,200   $ 10,200      
Share-based Compensation, Performance Measure Percent, Peer TSR 52.20%   52.20%      
Share-based Compensation, Performance Measure Percent, MSCI US REIT Index TSR 26.10%   26.10%      
Share-based Compensation, Performance Measure Percent, Growth in AFFO per share 21.70%   21.70%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum     3.60%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate     22.00%      
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Term     3 years      
Share-based Payment Arrangement, Expense     $ 3,000 2,800    
Severance Costs     $ 600      
Performance Shares [Member] | Granted in 2023            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period     209,238      
Performance Shares [Member] | Market Condition            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share Based Compensation Arrangement, Equity Instrument, Other Than Options, Market Condition, Grant Date Fair Value $ 5,400 $ 6,300 $ 5,400 $ 6,300    
Performance Shares [Member] | Market Condition | Granted in 2023            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     250.00%      
Performance Shares [Member] | Performance Condition | Granted in 2025            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     173.00%      
Share-based Compensation Arrangement, Equity Instruments Other Than Options, Performance Condition, Nonvested, Grant Date Fair Value           $ 2,100
Performance Shares [Member] | Performance Condition | Granted in 2023            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Fair value of non-vested shares     $ 15,200      
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period     0      
Performance Shares [Member] | Performance Condition | Granted in 2026            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share-based Compensation Arrangement by Share-based Payment Award, Award Vesting Rights, Percentage     162.00%      
Share-based Compensation Arrangement, Equity Instruments Other Than Options, Performance Condition, Nonvested, Grant Date Fair Value           $ 2,100
Dividend Equivalents | Performance Condition | Granted in 2023            
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]            
Share-Based Compensation Arrangement by Share-Based Payment Award, Shares Issued in Period     53,141